2-tert-Butyloxycarbonylaminomethyl-5-thiophen-2-yl-[1,3,4]oxadiazole, 95.0%, 1g

2-Butoxyaniline, 250mg

tert-Butyl 3-bromo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate, 95.0%, 1g

Diméthylsulfoxyde (DMSO), 5L, emballage plastique., >=99.0%, pour la synthèse

(1-(4-FLUOROPHENYL)-4-METHYL-1H-1,2,3-TRIAZOL-5-YL)METHANOL, 95.0%, 2g

Ethyl (Phenylthio)acetate, 97.0%, 10g

(2-Chloro-4-(trifluoromethyl)phenyl)hydrazine hydrochloride, 95.0%, 25g

1-BOC-2-(BROMOMETHYL)AZETIDINE, 95.0%, 1g

2-Amino-4,5-dimethoxybenzoic Acid>98.0%(HPLC)(T)10g

tert-Butyl 4-[2-(dimethylamino)acetamido]piperidine-1-carboxylate, 95.0%, 1g

Ethyl 2-cyano-2-methylpropanoate, 95.0%, 25g

Tetramethylammonium iodide, 95.0%, 5g

5-Bromo-3-methylbenzene-1,2-diamine, 95.0%, 25g